NCT03568656 2025-08-08Study to Evaluate CCS1477 in Advanced TumoursCellCentric Ltd.Phase 1/2 Completed220 enrolled
NCT01317641 2017-03-29Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate CancerOrion Corporation, Orion PharmaPhase 1/2 Completed136 enrolled 28 charts